Zacks analysts give Orthofix shares a ‘strong buy’ rating — 4 quick facts

Zacks analysts gave Orthofix International a “strong buy” rating, according to Intercooler.

Advertisement

Here are four quick facts:

 

1. The analysts set a one-year consensus price target of $48 for Orthofix shares.  

 

2. For the current quarter, Zacks analysts predict Orthofix will post $0.16 earnings per share.

 

3. On Jan. 14, Orthofix shares opened at $39.23.

 

4. The company has a market cap of $741.02 million.

 

More articles on devices:
SeaSpine, K2M, Smith & Nephew & more: 19 key notes
DeGen Medical launches Hyper-C Anterior Cervical Plate System: 4 key notes
Medical Compression Systems seeks buyer: 3 things to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.